A double-blind randomized trial included @ selected patients with a confirmed diagnosis of tubal pregnancy who met the inclusion criteria ( hemodynamic stability , initial serum - hCG concentration < @,@ mIU/mL , declining titers of - hCG @ h prior to treatment , visible tubal pregnancy on transvaginal ultrasound , a tubal mass < @ cm and fertility desire ) .